ACHIEVE LIFE SCIENCES, INC.

Nasdaq:ACHV

In Vitro & In Vivo Diagnostic Substances·SEATTLE, WA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

31 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/11/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

49 shown

Filed	Type	Description
10/7/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/27/25	Agreement	Entry into a Material Definitive Agreement	→
6/6/25	Vote	Submission of Matters to a Vote of Security Holders	→
2/10/25	Other	Other Events	→
1/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/23/26	S-3	S-3	→
6/27/25	424B5	424B5	→
6/26/25	424B5	424B5	→
4/28/25	ARS	ARS	→
1/10/25	S-8	S-8	→
12/5/24	S-8	S-8	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Jan 30, 2026

0001193125-26-0318064

Jan 28, 2025

5.5 KB

Jan 30, 2026

0001193125-26-0318014

Jan 28, 2025

5.5 KB

Jan 30, 2026

0001193125-26-0317954

Jan 28, 2025

5.4 KB

Jan 30, 2026

0001193125-26-0317904

Jan 28, 2025

5.4 KB

Jan 30, 2026

0001193125-26-0317824

Jan 28, 2025

5.5 KB

Jan 30, 2026

0001193125-26-0317614

Jan 28, 2025

5.6 KB

EFFECT

Jan 29, 2026

9999999995-26-000355

—

1.9 KB

SCHEDULE 13G/A

Jan 29, 2026

0000038777-26-000017

—

21.5 KB

S-3

Jan 23, 2026

0001193125-26-021032S-3

—

1.5 MB

Jan 12, 2026

0001193125-26-0098313

Jan 1, 2026

19.9 KB

Dec 8, 2025

0001193125-25-3111994

Dec 4, 2025

5.5 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-005187

—

10.7 KB

SCHEDULE 13G/A

Nov 14, 2025

0001013594-25-001417

—

14.0 KB

10-Q

Nov 6, 2025

0001193125-25-26807410-Q

Sep 30, 2025

9.2 MB

8-K

Nov 6, 2025

0001193125-25-2680568-K

Nov 6, 2025

524.3 KB

Oct 21, 2025

0001193125-25-2452683

Oct 20, 2025

17.6 KB

8-K

Oct 7, 2025

0001193125-25-2335818-K

Oct 6, 2025

193.3 KB

Oct 3, 2025

0001193125-25-2303244

Oct 1, 2025

5.4 KB

Sep 22, 2025

0001193125-25-2114044

Sep 18, 2025

9.2 KB

Sep 22, 2025

0001193125-25-2113924

Sep 18, 2025

12.7 KB

Sep 19, 2025

0001193125-25-2084113

Sep 8, 2025

18.3 KB

8-K

Sep 11, 2025

0001193125-25-2014188-K

Sep 5, 2025

190.1 KB

Sep 8, 2025

0000950170-25-1136064

Sep 4, 2025

5.9 KB

Sep 8, 2025

0000950170-25-1135984

Sep 4, 2025

8.1 KB

Sep 8, 2025

0000950170-25-1135924

Sep 4, 2025

12.2 KB

25 filings shown

Filed	Form	Description
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEF 14A	DEF 14A	→
4/18/23	PRE 14A	PRE 14A	→
4/21/22	DEF 14A	DEF 14A	→
3/30/21	DEF 14A	DEF 14A	→
↓

ACHIEVE LIFE SCIENCES, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/30/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
1/30/26	4	4	→
↓

Filed	Form	Description
1/29/26	EFFECT	EFFECT	→
1/29/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G	SCHEDULE 13G	→
8/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓